Lumida
/TSHA
⌘K
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc

TSHA
$5.02USD-2.71%-0.14 today

MARKET CAP

1.6B

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$7

AI Summary

Stalk
TrimMedium

TSHA remains in medium-term distribution with active lower highs and lower lows under declining EMAs, trading near extreme oversold levels at the 200-day SMA. The medium-term bias is bearish, but short-term exhaustion and oversold RSI suggest caution on new shorts. Execution is best deferred into rallies toward the 9/20 EMA zone for rejection. The long-term uptrend stays intact above the rising 200-day SMA. Key risks include a relief bounce reclaiming the 20 EMA or a breakdown below the 200-day SMA invalidating core structural signals.

  • Breakthrough therapy designation and 100% early trial response rate accelerate BLA path.
  • Catalent manufacturing agreement ensures scalable supply for anticipated 2027 launch.
  • Net loss of $109M and $86.4M R&D spend in 2025 strain finances.
Full analysis →

Buying

8

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY20.69 M140.91 M+2.33 M+71.7%0.00%
RI

Rtw Investments, LP

Q2 2026

SELL13.56 M92.35 M+-119.99 K+51.0%0.79%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY3.04 M20.71 M+61.04 K+55.5%0.95%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW2.25 M15.32 M+2.25 M+0.0%0.07%
MM

Millennium Management LLC

Q2 2026

SELL2.13 M14.48 M+-1.15 M-1.3%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY1.71 M11.67 M+1.21 M+415.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY766.28 K5.16 M+11.50 K+67.9%0.00%
WP

Woodline Partners LP

Q2 2026

SELL513.83 K3.50 M+-513.83 K-23.8%0.01%
MC

Moore Capital Management, LP

Q2 2026

BUY358.37 K2.44 M+29.54 K+66.0%0.04%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY189.33 K1.29 M+106.31 K+247.4%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL128.76 K876.88 K+-48.55 K+10.6%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY138.00 K616.17 K+69.00 K+62.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-461.86 K-100.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-413.20 K-100.0%0.00%